 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Traci Lyons and Heather Fairchild.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.178 |
|
|
|
-
Steinmetz RN, Wessells V, Fairchild H, Borges VF, Lyons TR. Targeting Semaphorin 7a Signaling in Preclinical Models of Endocrine Therapy-Resistant Breast Cancer. Mol Cancer Ther. 2026 Apr 27; OF1-OF15.
Score: 0.245
-
Steinmetz RN, Wessells V, Fairchild H, Lyons TR. Targeting Semaphorin 7a signaling in preclinical models of endocrine therapy-resistant breast cancer. Mol Cancer Ther. 2026 Mar 03.
Score: 0.242
-
Kines KT, Fairchild HR, Elder AM, Cozzens LM, Strugar ZP, Wessells VM, Becks AR, Porter WW, Borges VF, Lyons TR. Aging-induced semaphorin 7a promotes TGF-ß1-mediated cell plasticity and breast tumor metastases. Cell Rep. 2025 Aug 26; 44(8):116042.
Score: 0.233
-
Steinmetz RN, Wessells V, Fairchild H, Lyons TR. Targeting Semaphorin 7a signaling in preclinical models of estrogen receptor-positive breast cancer. bioRxiv. 2025 May 29.
Score: 0.230
-
Elder AM, Fairchild HR, Kines KT, Cozzens LM, Becks AR, Slansky JE, Anderson SM, Lyons TR. Semaphorin7A and PD-L1 cooperatively drive immunosuppression during mammary involution and breast cancer. Cell Rep. 2025 May 27; 44(5):115676.
Score: 0.229
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|